Stay updated on the progress of our pioneering endeavors.

The "2019 Annual Summit of China Chemical Pharmaceutical Industry" jointly organized and recommended by China Chemical Pharmaceutical Industry Association, China Pharmaceutical Business Association, China Non-Prescription Drug Association, China Pharmaceu

Recently, a drug-coated balloon for coronary intervention named "RESTORE paclitaxel-releasing coronary balloon dilatation catheter" (trade name: RESTORE DEB) has officially obtained the medical device registration certificate issued by the National Medica

On August 25, 2019, the 2019 (36th) National Medicinal Industry Information Annual Conference, China Grand Enterprises ranked the 13th in the list again with its strength。

On July 29, the Wuhan Federation of Industry and Commerce, Wuhan Enterprises Federation and Wuhan Entrepreneurs Association jointly released the 2019 ranking lists of “Top 100 Private Enterprises in Wuhan” and “Top 100 Private Manufacturing Enterprises in

Fortune China unveiled the latest “Fortune China 500” list on its website on July 10, 2019. Huadong Medicine Co., Ltd. (hereinafter “Huadong Medicine”) ranks 287th on the list. This is the eighth successive year that Huadong Medicine was inscribed onto the list.

According to Grand Pharma, it is expected that the application of this new drug in China will be sped up in order to benefit a greater number of patients in the country as soon as possible.